상악동암의 방사선치료와 생존율

Radiation Treatment and Survival of Maxillary Sinus Carcinoma

Irradiated 88 patients of .Maxillary Sinus Carcinoma at Yonsei Cancer Center for 10years between 1971 and 1980 were retrospectively analysed. The majority of patients had very advanced disease (87.5% of T3 and T4) and 17% of cervical lymph node involvement. 80.6% of all patients were epidermoid type. In 44 cases (50%), irradiation alone was performed. 28 cases (32%) of postoperative radiation after incomplete surgery and the remaining 16 cases (18%) of postopera tive radiation after radical surgery were done. The majority of patients except 6 cases had irradiation a dose between 60Gy and 80Gy in 30-40 fractions over 6 -8 weeks. The actuarial overall 3 and 5 year survival rate were 362% and 26%, respectively. The actuarial 5 year survival rate for 44 cases of radiation alone group was 14.l %, The actuarial 5 year survival rate for 28 cases of incomplete surgery and postoperative radiation group and 16 cases of radical surgery and postoperative radiation group were 312% and 67.4% respectively. In the actuarial 5 year survival rate according to the stage, stage II, Ill and IV were 79.5%, 20.90% and 0%. In recent, for the improvement of survival rate of advanced Maxillary Sinus Carcinoma at Yonsei Cancer Center, combined multidisplinary or trimodal treatment modality have been applied and in near time the more excellent results expect to be analyse.